Wissenschaft und Lehre
- European Society for Paediatric Oncology (SIOPE), Vorstandsmitglied
- European Society for Medical Oncology (ESMO), Sarcoma Faculty
- ESMO/SIOPE Cancer in Adolescents and Young Adults Working Group – Co-Chair
- International Society of Paediatric Oncology (SIOP), Scientific Programme Advisory Committee (SPAC)
- UK National Cancer Research Institute (NCRI), Clinical Trials Advisory and Awards Committee
- Faculty of 1000 (F1000Prime / Faculty / Oncology / Paediatric Oncology)
- Mitglied zahlreicher Studienkommissionen der GPOH
- Mitgliedschaft in Editorial Boards internationaler Fachzeitschriften
- Cancer Treatment Reviews
- Journal of Adolescent and Young Adult Oncology
Medizinisch-wissenschaftlichen Studien
- Cooperative Osteosarkomstudiengruppe (COSS) der Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH)
(Studiengruppenleitung: Prof. Dr. S. Bielack) - Cooperative Weichteilsarkom Studiengruppe (CWS) der Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH)
(Studiengruppenleitung: Prof. Dr. M. Sparber-Sauer, Stuttgart und PD Dr. Martin Ebinger, Tübingen)
- AIEOP-BFM ALL 2017: Phase III
International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia (EudraCT Nr. 2016-001935-12)
- EsPhALL2017/COGAALL1631: Phase III
Internationale Therapiestudie zur Behandlung von Kindern und Jugendlichen mit Philadelphia-Chromosom-positiver Akuter Lymphoblastischer Leukämie (EudraCT-Nr. 2017-000705-20)
- IntReALL HR 2010: Phase II
International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010 (EudraCT-Nr. 2012-000810-12)
- Register AML-BFM 2017:
zur Erfassung akuter myeloischer Leukämien bei Kindern und Jugendlichen
Morbus Hodgkin (HL)
- GPOH-HD Study Registry
Prospective Registry for children and adolescents with classical Hodgkin Lymphoma, nodular lymphocyte-predominant Hodgkin Lymphoma and relapsed Hodgkin Lymphoma
Non-Hodgkin Lymphome (NHL)
- NHL-BFM Registry 2012 :
Registry of the NHL-BFM study group for all subtypes of Non-Hodgkin Lymphoma diagnosed in children and adolescents - B-NHL 2013: Phase III
Treatment protocol of the NHL-BFM and the NOPHO study groups for mature aggressive B-cell lymphoma and leukemia in children and adolescents (EudraCT-Nr: 2013-003253-21) - LBL 2018: Phase III
International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma (EudraCT-Nr. 2017-001691-39) - ALCL-VBL: Phase III
International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine (EudraCT-Nr. 2017-002935-40)
- CPT-SIOP Register:
Internationales CPT-SIOP Register zu Choroid-Plexus-Tumoren - I-HIT-MED Registry:
For Children, adolescents, and adults with medulloblastoma, ependymoma, pineoblastoma, CNS-primitive neuroectodermal tumors - PNET-5MB: Phase II
An international prospective study on clinically strandard-risk Medulloblastoma in children older than 3 to 5 years with low-risk biological profile (PNET-5MB-LR) or average-risk biological profile (PNET5MB-SR) (EudraCT Nr. 2011-004868-30) - SIOP Ependymoma II: Phase II/III
An international clinical program for the diagnosis and treatment of children, adolescents and young adults with ependymoma (EudraCT-Nr. 2013-002766-39) - Kraniopharyngeom 2007:
Prospektive, multizentrische Untersuchung von Kindern und Jugendlichen mit Kraniopharyngeom - HIT-REZ-Register:
Multinationales multizentrisches Register für Kinder, Jugendliche und junge Erwachsene mit therapierefraktären, progredienten oder rezidivierten Medulloblastomen, Pineoblastomen, primitiv neuroektdermalen Tumoren des ZNS (ZNS-PNETs) und Ependymomen - Molecular Neuropathology Int-R:
Molecular data Generation and Clinical Follow-up within the International Molecular Neuropathology Registry - RIST-rPB-2015-P: (Studienende 30.04.2021): Phase II
Prospective pilot trial to assess a multimodal molecular targeted therapy in children, adolescent and young adults with relapsed or refractory high-grade pineoblastoma (EudraCT-Nr.: 2015-004304-27) - HIT-HGG-2013: Phase IIII
International cooperative phase III trial of the HIT-HGG study group for the treatment of high grade glioma, diffuse intrinsic pontine glioma, and gliomatosis cerebri in children and adolescents <18 years (EudraCT Nr. 2013-004187-56) - LOGGIC-Core:
BioClinical Data Bank for Low Grade Glioma in Children - HIT-LOGGIC-Register:
Prospektives multizentrisches Register für kinder und Jugendliche mit einem niedriggradigen Gliom
Osteosarkom
- COSS-Register:
Weiterführung der Registrierung von Knochensarkompatienten in das Register der Cooperativen Osteosarkomstudiengruppe (COSS)
Ewing-Sarkom
- rEECur: Phase II
International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent an Primary Refractory Ewing Sarcoma (EudraCT-Nr: 2014-000259-99) - iEwing Registry
International Euro Ewing Registry
Weichteilsarkom/-tumor
Neuroblastom
- NB-SCI-Register:
Prospective study registry of peripheral neuroblastic tumours presenting with spinal canal involvement (SCI) - NB Registry 2016:
Registry for neonates, infants, children, adolescents, and adults with newly diagnosed and/or relapsed neuroblastic tumors
Nephroblastom
- Umbrella SIOP-RTSG 2016:
Integrated research and guidelines for standardized diagnostic and therapy for Renal Tumors
Lebertumoren
- LTR:
Register für Lebertumoren bei Kindern und Jugendlichen - PHITT: Phase III
Paediatric Hepatic International Tumour Trial (EudraCT-Nr. 2016-002828-85)
Rhabdoidtumoren
Endokrine Tumoren
Keimzelltumoren
- LCH-REG-DE-2013:
Deutsches Register für Langerhanszell Histiozytosen im Kindes- und Jugendalter - LCH-IV-G-2016: Phase III
German Treatment Optimization Study for Children with De Novo and Relapsed Langerhans cell Histiocytosis (LCH) as Part of the International Study LCH-IV (EudraCT-Nr: 2016-003568-38)
- LESS (Late Effects Surveillance System):
Multizentrische prospektive Erfassung von Spätfolgen bei Krebserkrankungen des Kindes- und Jugendalters (vor allem ALL, Hirntumoren, Sarkome, embryonale Tumoren) - RiSK:
Register für behandlungsassoziierte Spätfolgen nach Strahlentherapie maligner Erkrankungen im Kindes- und Jugendalter - Care for CAYA
Comprehensive Assessments and Related interventions to Enhance long-term outcome in Children, Adolescents and Young Adults
- Bayer SCOUT 20290: Phase I/II
A Phase 1/2 Study of the Oral TRK Inhibitor LOXO-101 in Pediatric Patients with Advanced Solid or Primary Central Nervous System Tumors (EudraCT-Nr.: 2016-003498-16) - INFORM Registry:
Individualized Therapy For Relapsed Malignancies in Childhood - PRST:
Pädiatrisches Register für Stammzelltransplantation - LFS-CPS-R01:
Li-Fraumeni-Syndrome-Cancer-Predisposition-Syndrome Registry 01
- EWOG-SAA 2010:
Genetic and Immunological Characterization of Acquired Severe Aplastic Anemia (SAA) in Children and Adolescents. - Fanconi Anemia- Registry 01
www.kinderblutkrankheiten.de/content/fachinformationen/studienportal/studien_und_register/fanconi_register_far01/ - Register Sichelzellkrankheit
https://www.kinderblutkrankheiten.de/content/fachinformationen/studienportal/studien_und_register/register_sichelzellkrankheit/ - HLH-Registry:
A registry for hemophagocytic lymphohistiocytosis (HLH) - SCNIR:
European Protocol of the severe chronic neutropenia international registry - GEPHARD-Studie:
Qualitätsprojekt Neu diagnostizierte Hämophilie der Ständigen Kommission Pädiatrie Gesellschaft für Thrombose und Hämostaseforschung – GTH - Seltene Anämien
Multizentrisches, retro- und prospektives, nicht-interventionelles Register, Aufbau einer Biobank
- GEPHARD-Studie:
Nationales Register für neu diagnostizierte Kinder mit Hämophilie unter der Schirmherrschaft der Gesellschaft für Thrombose und Hämostaseforschung - Faktor IX-Inhibitor Register
Hemmkörper-Patienten mit Hämophilie B - DHR
Deutsches Hämophilie-Register
- LFS-CPS-R01:
Li-Fraumeni-Syndrome-Cancer-Predisposition-Syndrome Registry 01
Publikationen
-
Bielack S, Fox CP, Hoang-Xuan K, Giró-Perafita A, Rizzari C.
A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK.
Health Sci Rep. 2024 Jan 5;7(1):e1749. doi: 10.1002/hsr2.1749. 2024 Publication Link -
Mettmann VL, Blattmann C, Friedel G, Harrabi S, von Kalle T, Kager L, Kevric M, Kühne T, Nathrath M, Sorg B, Werner M, Bielack SS, Hecker-Nolting S.
Primary Multi-Systemic Metastases in Osteosarcoma: Presentation, Treatment, and Survival of 83 Patients of the Cooperative Osteosarcoma Study Group.
Cancers (Basel). 2024 Jan 8;16(2):275. doi: 10.3390/cancers16020275 2024 Publication Link -
Scobioala S, Parfitt R, Matulat P, Byrne J, Langer T, Troschel FM, Hesping AE, Clemens E, Kaatsch P, Grabow D, Kaiser M, Spix C, Kremer LC, Calaminus G, Baust K, Kuehni CE, Weiss A, Strebel S, Kuonen R, Elsner S, Haupt R, Garré ML, Gruhn B, Kepak T, Kepakova K, Winther JF, Kenborg L, Rechnitzer C, Hasle H, Kruseova J, Luks A, Lackner H, Bielack S, Beck JD, Jürgens H, van den Heuvel-Eibrink MM, Zolk O, Eich HT, Am Zehnhoff-Dinnesen A; PanCareLIFE Consortium.
The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium.
Int J Cancer. 2024 Jan 15;154(2):320-331. doi: 10.1002/ijc.34732. 2024 Publication Link
-
Eichholz T, Döring M, Giardino S, Gruhn B, Seitz C, Flaadt T, Schwinger W, Ebinger M, Holzer U, Mezger M, Teltschik HM, Sparber-Sauer M, Koscielniak E, Abele M, Handgretinger R, Lang P.
"Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas. "
"Front Oncol. 2023 Feb 21;13:1064190. doi: 10.3389/fonc.2023.1064190. eCollection 2023. PMID: 36895486" 2023 -
Sparber-Sauer M, Dietzschold M, Schönstein A, Heinz A, Vokuhl C, Pajtler KW, Harrabi S, Lin YL, Kalle TV, Hagen R, Ladenstein R, Kazanowska B, Ljungman G, Klingebiel T, Ebinger M, Koscielniak E, Münter M, Timmermann B; CWS Study Group.
"Radiotherapy and long-term sequelae in pediatric patients with parameningeal rhabdomyosarcoma: Results of two Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. "
"Pediatr Blood Cancer. 2024 Jan;71(1):e30742. doi: 10.1002/pbc.30742. Epub 2023 Oct 25. PMID: 37880926" 2023 -
Heinz AT, Schönstein A, Ebinger M, Fuchs J, Timmermann B, Seitz G, Vokuhl C, Münter M, Pajtler KW, Stegmaier S, von Kalle T, Kratz CP, Ljungman G, Juntti H, Klingebiel T, Koscielniak E, Sparber-Sauer M; Cooperative Weichteilsarkom Studiengruppe.
"Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR. "
"Pediatr Blood Cancer. 2024 Jan;71(1):e30707. doi: 10.1002/pbc.30707. Epub 2023 Oct 9. PMID: 37814424" 2023 -
Trama A, Stark D, Bozovic-Spasojevic I, Gaspar N, Peccatori F, Toss A, Bernasconi A, Quarello P, Scheinemann K, Jezdic S, Blondeel A, Mountzios G, Bielack S, Saloustros E, Ferrari A.
Cancer burden in adolescents and young adults in Europe.
ESMO Open. 2023 Feb;8(1):100744. doi: 10.1016/j.esmoop.2022.100744 2023 Publication Link -
Sparber-Sauer M, Corradini N, Affinita MC, Milano GM, Pierron G, Carton M, Tirode F, Pissaloux D, Alaggio R, Vokuhl C, Bisogno G, Berlanga P, Ferrari A, Orbach D.
Clinical characteristics and outcomes for children, adolescents and young adults with "CIC-fused" or "BCOR-rearranged" soft tissue sarcomas: A multi-institutional European retrospective analysis
"Cancer Med. 2023 Jul;12(13):14346-14359. doi: 10.1002/cam4.6113. Epub 2023 May 22. PMID: 37212486" 2023 -
Kolodziejczak AS, Guerrini-Rousseau L, Planchon JM, Ecker J, Selt F, Mynarek M, Obrecht D, Sill M, Autry RJ, Stutheit-Zhao E, Hirsch S, Amouyal E, Dufour C, Ayrault O, Torrejon J, Waszak SM, Ramaswamy V, Pentikainen V, Demir HA, Clifford SC, Schwalbe EC, Massimi L, Snuderl M, Galbraith K, Karajannis MA, Hill K, Li BK, Walsh M, White CL, Redmond S, Loizos L, Jakob M, Kordes UR, Schmid I, Hauer J, Blattmann C, Filippidou M, Piccolo G, Scheurlen W, Farrag A, Grund K, Sutter C, Pietsch T, Frank S, Schewe DM, Malkin D, Ben-Arush M, Sehested A, Wong TT, Wu KS, Liu YL, Carceller F, Mueller S, Stoller S, Taylor MD, Tabori U, Bouffet E, Kool M, Sahm F, von Deimling A, Korshunov A, von Hoff K, Kratz CP, Sturm D, Jones DTW, Rutkowski S, van Tilburg CM, Witt O, Bougeard G, Pajtler KW, Pfister SM, Bourdeaut F, Milde T
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
Neuro Oncol. 2023 Dec 8;25(12):2273-2286. 2023 -
Das A, Fernandez NR, Levine A, Bianchi V, Stengs LK, Chung J, Negm L, Dimayacyac JR, Chang Y, Nobre L, Ercan AB, Sanchez-Ramirez S, Sudhaman S, Edwards M, Larouche V, Samuel D, Van Damme A, Gass D, Ziegler DS, Bielack SS, Koschmann C, Zelcer S, Yalon-Oren M, Campino GA, Sarosiek T, Nichols KE, Loret De Mola R, Bielamowicz K, Sabel M, Frojd CA, Wood MD, Glover JM, Lee YY, Vanan M, Adamski JK, Perreault S, Chamdine O, Hjort MA, Zapotocky M, Carceller F, Wright E, Fedorakova I, Lossos A, Tanaka R, Osborn M, Blumenthal DT, Aronson M, Bartels U, Huang A, Ramaswamy V, Malkin D, Shlien A, Villani A, Dirks PB, Pugh TJ, Getz G, Maruvka YE, Tsang DS, Ertl-Wagner B, Hawkins C, Bouffet E, Morgenstern DA, Tabori U.
Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: A report from the International RRD Consortium.
Cancer Discov. 2023 Oct 12. doi: 10.1158/2159-8290. 2023 Publication Link -
Bielack SS, Kager L, Kühne T, Langer T, Reichardt P, Blattmann C, Kevric M, Mettmann V, Sorg B, Hecker-Nolting S.
Establishment, Maintenance, and Performance of the Cooperative Osteosarcoma Study Group (COSS).
Cancers (Basel). 2023 Feb 28;15(5):1520. doi: 10.3390/cancers15051520. 2023 Publication Link -
van Ewijk R, Herold N, Baecklund F, Baumhoer D, Boye K, Gaspar N, Harrabi SB, Haveman LM, Hecker-Nolting S, Hiemcke-Jiwa L, Martin V, Fernandez CM, Palmerini E, van de Sande MAJ, Strauss SJ, Bielack SS, Kager L.
European standard clinical practice recommendations for children and adolescents with primary and recurrent osteosarcoma
EJC Paediatr Oncol 2 (2023) 100029 2023 Publication Link -
Maennlin S, Chaika M, Gassenmaier S, Grimm R, Sparber-Sauer M, Fuchs J, Schmidt A, Ebinger M, Hettmer S, Gatidids S, Dittmann H, Schäfer JF.
Evaluation of functional and metabolic tumor volume using voxel-wise analysis in childhood rhabdomyosarcoma
"Pediatr Radiol. 2023 Mar;53(3):438-449. doi: 10.1007/s00247-022-05540-2. Epub 2022 Nov 18. PMID: 36399161" 2023 -
" Orbach D, Sparber-Sauer M, Corradini N, Ferrari A, Owens C, Casanova M."
Infantile fibrosarcoma: Is spontaneous regression possible?
"Pediatr Blood Cancer. 2023 Nov;70(11):e30623. doi: 10.1002/pbc.30623. Epub 2023 Aug 14. PMID: 37580894" 2023 -
Schoot RA, Orbach D, Minard Colin V, Alaggio R, Di Carlo D, Corradini N, Mercolini F, Milano GM, van Noesel MM, Rome A, Dall'Igna P, Pajtler K, Sparber-Sauer M, Ferrari A, Casanova M.
Inflammatory Myofibroblastic Tumor With ROS1 Gene Fusions in Children and Young Adolescents.
"JCO Precis Oncol. 2023 Sep;7:e2300323. doi: 10.1200/PO.23.00323. PMID: 37856763" 2023 -
Schoot RA, van Ewijk R, von Witzleben AA, Kao SC, Merks JHMH, Morosi C, Pace E, Shulkin BL, Ferrari A, von Kalle T, van Rijn RR, Weiss AR, Sparber-Sauer M, Ter Horst SAJ, McCarville MB.
INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) consensus statement: Imaging recommendations for the management of rhabdomyosarcoma.
"Eur J Radiol. 2023 Sep;166:111012. doi: 10.1016/j.ejrad.2023.111012. Epub 2023 Jul 25. PMID: 37541182" 2023 -
Lautz TB, Martelli H, Fuchs J, Chargari C, Smeulders N, Granberg CF, Wolden SL, Sparber-Sauer M, Hawkins DS, Bisogno G, Koscielniak E, Rodeberg DA, Seitz G; INSTRuCT group.
Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children's Oncology Group, the European Soft-Tissue Sarcoma Group, and the Cooperative Weichteilsarkom Studiengruppe.
"Pediatr Blood Cancer. 2023 May;70(5):e28601. doi: 10.1002/pbc.28601. Epub 2020 Aug 6. PMID: 32762004 " 2023 -
Gotta J, Bochennek K, Klingebiel T, Bielack S, Wild PJ, Demes MC, Gradhand E.
Metachronous Osteosarcoma, A Differential Diagnosis to be Considered in Children With Osteosarcoma: A Review of Literature and a Case From Our Center.
J Pediatr Hematol Oncol. 2023 Apr 1;45(3):105-110. doi: 10.1097/MPH.0000000000002560. 2023 Publication Link -
Dhaenens BAE, Mahler F, Batchelor H, Dicks P, Gaillard S, Nafria B, Kopp-Schneider A, Ribeiro MA, Schwab M, Sparber-Sauer M, Leubner J, de Wildt SN, Oostenbrink R.
Optimizing expert and patient input in pediatric trial design: Lessons learned and recommendations from a collaboration between conect4children and European Patient-CEntric ClinicAl TRial PLatforms.
"Clin Transl Sci. 2023 Aug;16(8):1458-1468. doi: 10.1111/cts.13547. Epub 2023 Jun 30. PMID: 37391924" 2023 -
Bielack SS, Blattmann C, Hassenpflug W, Kager L, Kuhne T, Kevric M, Schlegel PG, Mettmann V, Sorg B, Hecker-Nolting S.
Osteosarcoma Arising After Ewing Sarcoma or Vice Versa: A Report of 20 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS).
Anticancer Res. 2023 Nov;43(11):4975-4981. doi: 10.21873/anticanres.16696. 2023 Publication Link -
Hecker-Nolting S, Baumhoer D, Blattmann C, Kager L, Kühne T, Kevric M, Lang S, Mettmann V, Sorg B, Werner M, Bielack SS.
Osteosarcoma pre-diagnosed as another tumor: a report from the Cooperative Osteosarcoma Study Group (COSS).
J Cancer Res Clin Oncol. 2023 May;149(5):1961-1967. doi: 10.1007/s00432-022-04156-1. 2023 Publication Link -
Bielack SS, Lindner LH, Egerer G, Benzler K, Blattmann C, Grube M, Hahn D, Kager L, Kühne T, Mettmann V, Reichardt P, Hecker-Nolting S.
Osteosarcomas in older adults: A report from the Cooperative Osteosarcoma Study Group.
J Geriatr Oncol. 2023 Apr;14(3):101445. doi: 10.1016/j.jgo.2023.101445. 2023 Publication Link -
Palmerini E, Reichardt P, Hall KS, Bertulli R, Bielack SS, Comandone A, Egerer G, Hansmeier A, Kevric M, Carretta E, Hansson L, Jebsen N, Eriksson M, Bruland ØS, Donati DM, Ibrahim T, Smeland S, Ferrari S.
Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.).
Cancer. 2023 Nov 15;129(22):3564-3573. doi: 10.1002/cncr.34964. 2023 Publication Link -
Tramsen L, Bochennek K, Sparber-Sauer M, Salzmann-Manrique E, Scheer M, Dantonello T, Borkhardt A, Dirksen U, Thorwarth A, Greiner J, Ebinger M, Weclawek-Tompol J, Ladenstein R, Ljungman G, Hallmen E, Lehrnbecher T, Koscielniak E, Klingebiel T.
Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials.
"Cancers (Basel). 2023 Mar 30;15(7):2050. doi: 10.3390/cancers15072050. PMID: 37046711 " 2023 -
Bodmer N, Hecker-Nolting S, Friedel G, Blattmann C, Kager L, Kessler T, Kevric M, Kühne T, Mettmann V, Müller-Abt P, Sorg B, Theobald M, Bielack SS.
Primary osteosarcoma of the ribs: A report from the Cooperative Osteosarcoma Study Group.
Cancer. 2023 Jun 15;129(12):1895-1903. doi: 10.1002/cncr.34744. 2023 Publication Link -
Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jürgens H, Winkler K.
Prognostic Factors in High-Grade Osteosarcoma of theExtremities or Trunk: An Analysis of 1,702 Patients Treatedon Neoadjuvant Cooperative Osteosarcoma Study GroupProtocols.
J Clin Oncol. 2023 Sep 20;41(27):4323-4337. doi: 10.1200/JCO.22.02767. 2023 Publication Link -
Heinz AT, Ebinger M, Schönstein A, Fuchs J, Timmermann B, Seitz G, Vokuhl C, Münter MW, Pajtler KW, Stegmaier S, von Kalle T, Kratz CP, Rößler J, Ljungman G, Klingebiel T, Koscielniak E, Sparber-Sauer M; Cooperative Weichteilsarkom Studiengruppe (CWS).
Second-line treatment of pediatric patients with relapsed rhabdomyosarcoma adapted to initial risk stratification: Data of the European Soft Tissue Sarcoma Registry (SoTiSaR).
"Pediatr Blood Cancer. 2023 Jul;70(7):e30363. doi: 10.1002/pbc.30363. Epub 2023 Apr 17. PMID: 37066598" 2023 -
Mettmann VL, Baumhoer D, Bielack SS, Blattmann C, Friedel G, von Kalle T, Kager L, Kevric M, Nathrath M, Sorg B, Dürken M, Hecker-Nolting S
Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group.
Cancer Med. 2023 Sep;12(17):18219-18234. 2023 -
Bielack SS, Palmerini E
Stand with Ukraine
Pediatr Blood Cancer. 2023;e30301. doi: 10.1002/pbc.30301 2023 DOI Link -
Bielack SS, Reichardt P, Lindner LH, Hecker-Nolting S
Systemische Therapie von Osteosarkomen
InFo Hämatologie + Onkologie 2023; 26 (3). doi: - 2023 -
Sparber-Sauer M, Ferrari A, Spunt SL, Vokuhl C, Casey D, Lautz TB, Meyer WH, Walterhouse DO, Pajtler KW, Alaggio R, Schmidt A, Safwat A, Timmermann B, Dall'Igna P, Chen S, Weiss AR, Orbach D.
The significance of margins in pediatric Non-Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)
"Cancer Med. 2023 May;12(10):11719-11730. doi: 10.1002/cam4.5671. Epub 2023 Feb 6. PMID: 36744538" 2023 -
Hecker-Nolting S, Kager L, Kühne T, Baumhoer D, Blattmann C, Friedel G, von Kalle T, Kevric M, Mayer-Steinacker R, Schwarz R, Sorg B, Wirth T, Bielack SS.
Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis.
J Adolesc Young Adult Oncol. 2023 Feb;12(1):76-82. doi: 10.1089/jayao.2021.0221. 2023 Publication Link